Search Results 81-90 of 21255 for B cell lymphomas
... B-Cell non-Hodgkin lymphoma (B-NHL) or frontline high-risk diffuse large B-cell lymphoma (DLBCL). Participation eligibility. Participant eligibility includes ...
Diffuse large B-cell lymphoma, NOS;. High-grade B-cell lymphoma (HGBL) (including HGBL with MYC and BCL2 and/or BCL6 rearrangements (DHL/THL) based on FISH ...
Research. Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ways to improve diagnosis and treatment for this ...
Study Of Lenzilumab And Axicabtagene Ciloleucel In Subjects With Relapsed Or Refractory Large B-cell Lymphoma · Share · Facebook · Twitter.
Giving lenalidomide with R-ICE may be a better treatment for patients with diffuse large B-cell lymphoma. Participation eligibility. Participant eligibility ...
Chimeric antigen receptor (CAR)-T cell therapy trains the immune system cells to fight follicular lymphoma. ... B-cell lymphomas. National Comprehensive Cancer ...
Moustafa and his co-author outlined the effectiveness of CAR-T cell therapy in extranodal diffuse large B-cell lymphoma (DLBCL), noting that it presents a " ...
... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...
A Study To Compare Tisagenlecleucel Vs. Standard Of Care In Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma · Share · Facebook · Twitter.
... Cell Or Follicular B-Cell Lymphoma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.